Zurich Cantonal Bank’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$119M Buy
1,374,551
+616,872
+81% +$59.1M 0.26% 71
2025
Q4
$72.8M Buy
757,679
+60,930
+9% +$5.92M 0.16% 118
2025
Q3
$66.4M Sell
696,749
-25,340
-4% -$2.33M 0.15% 115
2025
Q2
$62.9M Buy
722,089
+352,008
+95% +$29.9M 0.15% 119
2025
Q1
$33.3M Sell
370,081
-59,229
-14% -$5.3M 0.1% 185
2024
Q4
$34.3M Buy
429,310
+9,395
+2% +$813K 0.1% 182
2024
Q3
$37.8M Sell
419,915
-11,778
-3% -$991K 0.11% 158
2024
Q2
$34M Sell
431,693
-223,506
-34% -$18.3M 0.11% 152
2024
Q1
$57.1M Buy
655,199
+8,860
+1% +$756K 0.2% 96
2023
Q4
$53.2M Buy
646,339
+108,231
+20% +$8.25M 0.2% 92
2023
Q3
$42.2M Buy
538,108
+18,810
+4% +$1.57M 0.19% 100
2023
Q2
$45.8M Sell
519,298
-63,897
-11% -$5.5M 0.2% 99
2023
Q1
$47M Buy
583,195
+24,780
+4% +$2.02M 0.23% 91
2022
Q4
$43.4M Buy
558,415
+36,561
+7% +$2.96M 0.23% 91
2022
Q3
$42.1M Buy
521,854
+28,865
+6% +$2.59M 0.25% 82
2022
Q2
$44.2M Sell
492,989
-58,926
-11% -$5.97M 0.26% 81
2022
Q1
$61.2M Buy
551,915
+5,963
+1% +$630K 0.3% 68
2021
Q4
$56.5M Sell
545,952
-240,697
-31% -$27.9M 0.27% 71
2021
Q3
$98.6M Sell
786,649
-112,743
-13% -$14.6M 0.53% 28
2021
Q2
$112M Buy
899,392
+210,283
+31% +$26.4M 0.62% 23
2021
Q1
$81.4M Buy
689,109
+77,092
+13% +$9.04M 0.48% 35
2020
Q4
$71.7M Sell
612,017
-13,316
-2% -$1.47M 0.44% 36
2020
Q3
$65M Sell
625,333
-47,303
-7% -$4.75M 0.46% 39
2020
Q2
$61.7M Sell
672,636
-265,257
-28% -$25.4M 0.53% 29
2020
Q1
$84.6M Buy
937,893
+119,516
+15% +$12.7M 0.79% 20
2019
Q4
$92.8M Sell
818,377
-25,920
-3% -$2.84M 0.72% 22
2019
Q3
$91.7M Buy
844,297
+65,801
+8% +$6.87M 0.77% 22
2019
Q2
$75.8M Buy
778,496
+93,648
+14% +$8.55M 0.64% 24
2019
Q1
$62.4M Buy
684,848
+278,176
+68% +$24.9M 0.56% 27
2018
Q4
$37M Buy
406,672
+2,841
+0.7% +$265K 0.37% 48
2018
Q3
$39.7M Sell
403,831
-60,889
-13% -$5.63M 0.34% 54
2018
Q2
$39.8M Sell
464,720
-1,223
-0.3% -$102K 0.35% 54
2018
Q1
$37.4M Buy
465,943
+88,527
+23% +$7.3M 0.34% 54
2017
Q4
$30.5M Buy
377,416
+31,999
+9% +$2.56M 0.27% 78
2017
Q3
$26.9M Sell
345,417
-2,977
-0.9% -$247K 0.25% 87
2017
Q2
$30.9M Sell
348,394
-13,489
-4% -$1.14M 0.3% 67
2017
Q1
$29.2M Sell
361,883
-1,996
-0.5% -$156K 0.29% 79
2016
Q4
$25.9M Sell
363,879
-138,878
-28% -$10.9M 0.27% 86
2016
Q3
$43.4M Buy
502,757
+70,204
+16% +$6.12M 0.45% 43
2016
Q2
$37.5M Sell
432,553
-71,213
-14% -$5.76M 0.49% 43
2016
Q1
$37.8M Buy
503,766
+37,166
+8% +$2.8M 0.48% 46
2015
Q4
$35.9M Buy
466,600
+100,255
+27% +$7.55M 0.45% 45
2015
Q3
$24.5M Buy
366,345
+19,116
+6% +$1.41M 0.35% 67
2015
Q2
$25.7M Sell
347,229
-86,118
-20% -$6.58M 0.35% 67
2015
Q1
$33.8M Buy
433,347
+200,221
+86% +$15.2M 0.47% 55
2014
Q4
$16.8M Buy
233,126
+79,580
+52% +$5.53M 0.52% 33
2014
Q3
$9.51M Sell
153,546
-188,019
-55% -$12M 0.31% 63
2014
Q2
$21.8M Buy
341,565
+42,752
+14% +$2.6M 0.64% 27
2014
Q1
$18.4M Buy
298,813
+42,361
+17% +$2.47M 0.57% 34
2013
Q4
$14.7M Buy
256,452
+65,475
+34% +$3.71M 0.48% 37
2013
Q3
$10.2M Buy
190,977
+28,867
+18% +$1.55M 0.35% 61
2013
Q2
$8.34M Buy
+162,110
New +$8.01M 0.29% 79

Other funds holding MDT

Zurich Cantonal Bank's MDT Position: Q1 2026 in Review

Zurich Cantonal Bank increased its Medtronic (MDT) stake by 81% in Q1 2026, buying an estimated $59.1M and bringing the position to 1,374,551 shares worth $119M. The position accounts for 0.26% of the portfolio, ranked #71.

Zurich Cantonal Bank first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Zurich Cantonal Bank held 1,374,551 shares of Medtronic worth $119M as of Q1 2026.
  • Zurich Cantonal Bank bought 616,872 Medtronic shares in Q1 2026, an estimated $59.1M.
  • Medtronic made up 0.26% of Zurich Cantonal Bank's portfolio in Q1 2026, its #71 holding.
  • Zurich Cantonal Bank first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.